Literature DB >> 3180636

Persistent gastric-protective effect of antacid evaluated by measurement of transmucosal gastric potential difference.

J F Bergmann1, C Caulin, G Simoneau, G Dorf, J M Segrestaa.   

Abstract

The aim of this study was to determine the effect of 1 week of antacid dosing on the aspirin-induced potential differences (PDs) across the gastric mucosa. The study design was double blind and randomized with crossover. Ten healthy subjects received aluminum hydroxide gel, 8 gm t.i.d., or placebo for 1 week. They then received 1 gm aspirin after an overnight fast and the PD across the mucosa was measured. Baseline potentials were the same before both treatment periods. Antacids reduced the aspirin-induced PDs. The mean (+/- SD) maximal PD was 27.4 +/- 1.7 mV with placebo vs. 10.7 +/- 2.2 mV with antacids (p less than 0.001). Recovery time was 65.5 +/- 5.2 minutes with placebo vs. 29.0 +/- 6.7 minutes with antacids (p less than 0.001). These results suggest the effect is due to a longer-term cytoprotective property of antacids rather than to acid-neutralizing activity.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3180636     DOI: 10.1038/clpt.1988.192

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN: 0009-9236            Impact factor:   6.875


  2 in total

1.  Use of dimethicone to reduce the fall in gastric potential difference induced by bile salts.

Authors:  J F Bergmann; G Simoneau; G Chantelair; C Caulin; J M Segrestaa
Journal:  Eur J Clin Pharmacol       Date:  1989       Impact factor: 2.953

2.  What is the better formulation of microencapsulated potassium chloride?

Authors:  G Simoneau; J F Bergmann; R Pamphile; C Caulin; J M Segrestaa
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1994 Jan-Mar       Impact factor: 2.441

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.